Abiopharma

News list

Davis Kim 🟢 acquired 425.7K shares (1 derivative) of Zura Bio Ltd (ZURA) at $6.03 ($2.6M) Transaction Date: Apr 01, 2026 | Filing ID: 000002

Full text

News bot April 2, 2026, 10 p.m.
🔍 Davis Kim (Executive)

Company: Zura Bio Ltd (ZURA)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 425,700
Detailed Transactions and Holdings:
- Acquired 425,700 shares of Employee Share Option (Right to Buy) at $6.03 per share (Derivative)
  Date: 2026-04-01 | Code: A | Expires: 2036-04-01 | equity_swap_involved: 0 | shares_owned_after: 425,700.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.